Lipid Drug Conjugates: A Novel Approach for Drug Delivery A Systematic Review

Authors

  • N. Jawahar Pharmaceutics Research Laboratory, JSS College of Pharmacy, Udhagamandalam, A constituent College of JSS University, Mysore, India
  • K. Srikanth Pharmaceutics Research Laboratory, JSS College of Pharmacy, Udhagamandalam, A constituent College of JSS University, Mysore, India
  • S. N. Meyyanathan Pharmaceutics Research Laboratory, JSS College of Pharmacy, Udhagamandalam, A constituent College of JSS University, Mysore, India

DOI:

https://doi.org/10.37591/(rrjops).v3i3.939

Abstract

 

The lipid drug conjugates (LDCS) a novel lipid based nanoparticles which has been extensively employed for the delivery and targeting of drugs. These have been exploited for many features in the field of pharmaceutical technology. The lipid drug conjugates have a 33% drug loading capacity more than the solid lipid nanoparticles (SLNs). The lipid drug conjugates have the potential to act as a delivery system for hydrophilic and lipophilic drugs, which makes the delivery system suitable for brain targeting. Serum protein adsorption on lipid drug conjugate nanoparticles is a new carrier system for I. V. application. The particles were surface modified to target them to the brain which makes the lipid drug conjugates a promising delivery system.

Keywords: Lipid drug conjugate, nanoparticles, drug delivery

Downloads

Published

2021-01-14

Issue

Vol 1-3, No 3 (2010-12)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.